All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @caterina.beauty on TikTok · 69s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @caterina.beauty's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:02There are two caps of pink needle.
  2. 0:05First, remove the clear outer cap and put it aside.
  3. 0:10Then remove the inner cap and discard it.
  4. 0:13Now we need to clamp the pin.
  5. 0:18The needle is only planned the first time you use the pin.
  6. 0:21Turn the door style to the first line of the pin.
  7. 0:28Hold the pin with the needle pointing upwards and press the plunger.
  8. 0:34You should see a small stream or drop of medication.
  9. 0:38The door styles should return to zero.
  10. 0:42Push the needle all the way into the skin.
  11. 0:49Press the plunger at the end of the pin to inject the medication.
  12. 0:58When the door styles turn to zero, continue to hold out the prongers
  13. 1:04and count slowly to six seconds before removing the needle.

@caterina.beauty's Ozempic injection guide, fact-checked

Caterina Beauty

TikTok creator

56.4K viewsWatch on TikTok

Quick answer

The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time. The creator's instruction that priming occurs only once per pen is inconsistent with Novo Nordisk's prescribing information, which requires a flow check before each injection after attaching a new needle. No dose or indication guidance is given, which is appropriate for a lay tutorial, though the absence of injection site rotation advice is a clinically relevant omission.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @caterina.beauty's Ozempic injection guide, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@caterina.beauty's Ozempic injection guide, fact-checked" from Caterina Beauty. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time.

The reason this review is not generic is the source wording and the canonical claim label "glp1 howtouseozempic ozempicaustralia fyp australia how the." In this clip, the useful excerpt is: "There are two caps of pink needle." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A six-second post-injection hold is evidence-backed: Flood et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video demonstrates subcutaneous injection technique for a semaglutide pen device, covering needle attachment, priming, dose dialing, and post-injection dwell time. The creator's instruction that priming occurs only once per pen is inconsistent with Novo Nordisk's prescribing information, which requires a flow check before each injection after attaching a new needle. No dose or indication guidance is given, which is appropriate for a lay tutorial, though the absence of injection site rotation advice is a clinically relevant omission.
  • Prime the Ozempic pen before every injection after attaching a new needle, not only when opening a new pen for the first time.
  • A six-second post-injection hold is evidence-backed: Flood et al. (2022, Diabetes Therapy) linked premature withdrawal to measurable dose loss.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Prime the Ozempic pen before every injection after attaching a new needle, not only when opening a new pen for the first time.
  • A six-second post-injection hold is evidence-backed: Flood et al. (2022, Diabetes Therapy) linked premature withdrawal to measurable dose loss.
  • Injection site rotation across the abdomen, thigh, and upper arm is necessary to prevent lipohypertrophy, which impairs semaglutide absorption (Blanco et al., 2013, Diabetes Care).
  • In Australia, semaglutide is a Schedule 4 prescription-only drug under the TGA; obtaining it without a valid script is unlawful.
  • Ozempic and Wegovy contain the same active ingredient but are approved at different doses for different indications and cannot be used interchangeably without prescriber oversight.
  • Always attach a new needle for each injection: reusing needles increases infection risk and can cause needle tip deformation that affects dose accuracy.
  • Unopened Ozempic pens should be refrigerated at 2-8 degrees Celsius; in-use pens can be stored below 30 degrees for up to 56 days.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @caterina.beauty actually say?

The creator walked through the steps of priming and injecting with an Ozempic pen. She described removing two needle caps, priming the pen by turning the dose selector to "the first line" and pressing the plunger until medication appears, dialing the dose, inserting the needle fully, and holding the plunger for six seconds before removing. That is the basic shape of correct technique. But some of the language is muddled enough to cause real confusion.

She refers to the dose window as "door styles" throughout, which is clearly a speech or transcription artifact for "dose dial" or "dose window." She also says the needle "is only planned the first time you use the pin," which appears to mean priming is a once-off step. That is wrong, and it matters.

Does the science back this up?

The core injection sequence she describes is broadly consistent with Novo Nordisk's own prescribing information and patient guides for semaglutide (Ozempic). The six-second hold after pressing the plunger is real guidance, not invented. A 2022 review by Flood et al. in Diabetes Therapy found that inadequate needle dwell time is one of the most common causes of incomplete dose delivery with auto-injector and dial-a-dose pens.

The instruction to push the needle "all the way into the skin" is consistent with standard subcutaneous injection technique for most adults. Research published by Hirsch et al. (2014, Diabetes Technology and Therapeutics) confirmed that for most patients using 4mm or 5mm pen needles, a 90-degree insertion without skin lifting is appropriate and avoids intramuscular injection. Nothing in her technique advice contradicts this.

What did they get wrong (or right)?

The biggest error is the claim that priming is done only once, on the first use of the pen. Novo Nordisk's official Ozempic instructions are explicit: you prime the pen before every new needle is attached, not just at the start of a new pen. Every time you swap needles, air and small amounts of medication can enter the needle hub, and priming clears that. Skipping it risks delivering less medication than intended.

She gets the discard step right: the inner needle cap is thrown away, the outer cap is kept to remove the needle afterward. That is correct and actually important, since recapping with the outer cap before disposal reduces needlestick risk.

The six-second count before withdrawal deserves credit. It is not dramatic filler. Insulin and GLP-1 pen studies consistently show that patients who withdraw immediately after pressing the plunger lose a measurable amount of dose from the injection site. The six-second window allows pressure to dissipate and medication to disperse.

One genuine gap: she does not mention injection site rotation. Semaglutide should be rotated across the abdomen, thigh, and upper arm to prevent lipohypertrophy, a condition where repeated injections in the same spot cause fatty tissue buildup that impairs absorption (Blanco et al., 2013, Diabetes Care).

What should you actually know?

If you are using an Ozempic pen, prime it before every injection, not just the first time you open a new pen. Attach a fresh needle, point it up, dial to the flow check symbol, press until you see a drop or small stream of medication, then dial your prescribed dose. Do not use the dose your TikTok creator used. Your dose is between you and your prescribing clinician.

Australia's Therapeutic Goods Administration classifies semaglutide as a Schedule 4 prescription-only medication. Using it without a valid prescription is not legal, and sourcing it from unregulated suppliers carries serious risks including counterfeit product and incorrect concentration. Ozempic (0.5mg, 1mg, 2mg per dose) and Wegovy (2.4mg) are different products with different approved indications. They are not interchangeable without clinical oversight.

  • Prime before every injection, not just the first
  • Rotate injection sites each week to reduce tissue damage
  • Hold the plunger for at least six seconds before withdrawing
  • Store unused pens in the fridge; in-use pens can be kept at room temperature for up to 56 days
  • Always use a new needle for each injection to reduce infection risk and ensure accurate dosing

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Caterina Beauty · TikTok creator

56.4K views on this video

#howtouseozempic #ozempicaustralia #fyp #australia How the use ozempic pen.

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about prime the ozempic pen before every injection after attaching a?

Prime the Ozempic pen before every injection after attaching a new needle, not only when opening a new pen for the first time.

What does the video say about a six-second post-injection hold?

A six-second post-injection hold is evidence-backed: Flood et al. (2022, Diabetes Therapy) linked premature withdrawal to measurable dose loss.

What does the video say about injection site rotation across the abdomen, thigh,?

Injection site rotation across the abdomen, thigh, and upper arm is necessary to prevent lipohypertrophy, which impairs semaglutide absorption (Blanco et al., 2013, Diabetes Care).

What does the video say about in australia, semaglutide?

In Australia, semaglutide is a Schedule 4 prescription-only drug under the TGA; obtaining it without a valid script is unlawful.

What does the video say about ozempic?

Ozempic and Wegovy contain the same active ingredient but are approved at different doses for different indications and cannot be used interchangeably without prescriber oversight.

What does the video say about always attach a new needle for each injection: reusing needles?

Always attach a new needle for each injection: reusing needles increases infection risk and can cause needle tip deformation that affects dose accuracy.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Caterina Beauty, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.